Wordt geladen...
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
Antiangiogenesis options have evolved rapidly in the last few years, with an increasing number of agents currently approved by the US Food and Drug Administration and European Medicines Agency. Angiogenesis inhibitors have been shown to be very effective for the treatment of metastatic renal cancer...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3977458/ https://ncbi.nlm.nih.gov/pubmed/24715765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S37098 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|